Nima Rezaei to Immunoglobulins, Intravenous
This is a "connection" page, showing publications Nima Rezaei has written about Immunoglobulins, Intravenous.
Connection Strength
0.220
-
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci. 2020 Oct 01; 258:118185.
Score: 0.089
-
Preference of Genetic Diagnosis of CXCR4 Mutation Compared with Clinical Diagnosis of WHIM Syndrome. J Clin Immunol. 2017 04; 37(3):282-286.
Score: 0.070
-
Economic burden of common variable immunodeficiency: annual cost of disease. Expert Rev Clin Immunol. 2015 May; 11(5):681-8.
Score: 0.061